Dr. David B. Nash, Dean of the Jefferson College of Population Health, talks with P&T Editor Steve McIver about health care reform, value-based treatment, the opioid crisis, telehealth, vaccinations, and our less-than-healthy lifestyles—issues that call for hard work by governments, professions, industry, and every American.
Easier-to-clean Pentax device may help limit bacterial infections
First once-daily, single-inhaler triple therapy for the disease in the U.S.
Such drugs often block the serotonin that other organs need
Proprietary delivery system deposits proven steroid deep into the nose
Patient deaths related to other combination therapies concern the agency
Detailed procedures aim to protect patients from promising treatment’s toxicities
Generic opioid medications are cheaper
PFS worse with bendamustine and rituximab in new study
Single-dose oral therapy treats leading gynecological infection
Injection is also approved for GEP-NETs
Dr. David B. Nash Talks About Our Health Care Challenges
August 2017 interview